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Abstract
Gold(I) catalysts effectively promote the Cope rearrangement of acyclic 1,5-dienes bearing a
terminal cyclopropylidene. When this methodology is applied to cyclic substrates an unexpected
transformation occurs, resulting in the formation of a tricyclic compound incorporating a
bicyclo[4.2.0]oct-1-ene core, a portion of which is found in a number of natural products. Density
functional theory calculations (M06 and M06-2X) reveal insight into the mechanism and
thermodynamics of this unique transformation.
Transition-metal catalysts play a prominent role in promoting the kinetic viability of a
variety of synthetic reactions. When used in combination with thermodynamically favorable
transformations, like the consumption of C–C unsaturation1,2 and the release of ring
strain,3–11 numerous useful methodologies have emerged. The construction of complex
polycyclic structures from relatively simple starting materials has been the subject of a
number of research efforts aimed at accessing biomimetic carbocycles.12–16
In our own effort to utilize ring strain and unsaturation for biomimetic polycyclization
reactions, we discovered that 1,5-dienes with a terminal alkylidene cyclopropane
preferentially undergo Cope rearrangements instead of the expected cascade cyclizations
under Au(I) catalysis (Scheme 1).17 This reaction is driven thermodynamically by the relief
of ring strain in the cyclopropylidene moiety.18,19 In this paper, we extend the scope of this
rearrangement to cyclic substrates like 1 (R = Me, Ph) with the goal of using alkylidene
cyclopropane strain release to access medium sized carbocycles,20–22 which suffer from
their own strain (Scheme 1). To our surprise, the Cope rearrangement was seemingly not
followed, and tricyclic compounds 2, which feature a bicyclo[4.2.0]oct-1-ene core, are
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formed instead (eq 1). This bicyclic skeleton is present in a number of natural products
including welwitindolinone A, and the protoilludane class of sesquiterpenes.23–26
(1)
Employing 10 mol % of the Gagosz catalyst,27 Ph3PAuNTf2 (Tf =
trifluoromethanesulfonyl) allows the reaction to proceed cleanly over 12 h at room
temperature to a single product (2). The rearranged 2a and 2b are isolable via flash
chromatography in good yield (76% and 88% yield, respectively) and were identified by an
analysis of the NOESY NMR spectra of 2b. The assignment of 2a was made based on
similarities in the NMR spectra to 2b. Key correlations are shown in Figure 1.
The phenyl ring was assigned to the concave face of the molecule through a correlation
between HA (7.35 ppm) and HB (1.85 ppm), but not between HA and HC (1.50 ppm) (Figure
1a), as well as the signal between HD (3.40 ppm) and HE (1.75 ppm) (Figure 1b). The cis-
ring configuration was assigned by the key interactions between the diaxially oriented HE
(1.75 ppm) and HF (1.85 ppm), HG (1.90 ppm) with HI (3.0 ppm) (Figure 1c), and the
supporting resonance between HA and HB. A more in-depth discussion of the NOESY data
is provided in the Supporting Information.
To explore the scope of the reaction a series of additional substrates were synthesized,
varying in ring size and substitution on the pendant alkene (Scheme 2). These were obtained
in two steps from the cyclic enone via a Cu-mediated Michael addition at low temperature,
followed by a Wittig reaction. The former reactions were generally high yielding for
commercially available Grignard reagents (68–94%), but low yields were obtained from the
Grignard reagent prepared from α-bromostyrene (18–58%). The resulting ketone could be
transformed, in poor to moderate yield, into the desired substrate with
cyclopropyltriphenylphosphonium bromide and NaH, facilitated by the phase transfer
catalyst tris[2-(2-methoxyethoxy)ethyl]amine (TDA-1).33 It was hoped that the
cyclopentylidene and cycloheptylidene substrates would provide access to tricyclic
compounds that varied in ring structure (eqs 2 and 3, respectively).
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Unfortunately, the additional substrates gave neither the tricyclic products nor the analogous
originally hypothesized medium ring products. Despite considerable experimentation,
compounds 1c–e and 4a gave complex, intractable mixtures of compounds. Attempts to
optimize via choice of solvent (nitromethane, 1,2-dichloroethane) and catalyst (e.g., (R)-
BINAP(AuCl)2, (S)-xylyl-PHANEPHOS(AuCl)2), or activating agent (AgBF4, AgSbF6,
AgPF6) failed to simplify the reaction mixtures. It was observed that in the case of 4a the
identity of the counterion affected the ratio of products observed in the GC–MS but not the
number of species formed. For compounds 3a and 3b two major products were formed
along with a number of minor products. Control reactions with HCl·Et2O gave the same
products in the same ratios, as did a separate control reaction between 3a and AgPF6 in
DCM, suggesting unproductive, Brønsted acid catalyzed alkene isomerization pathways.
These isomerization reactions removed the ring strain of the methylenecyclopropane by
transformation of the exocyclic alkene into an endocyclic olefin (within the cyclopentyl ring,
see the Supporting Information). Identical control reactions with the 6- and 7-membered ring
substrate analogues were sluggish and did not produce the same reaction mixtures observed
as when Au(I) complexes were reacted. No tricyclic product was formed when the control




Insight into the reaction’s mechanism and limitations was achieved through density
functional theory (DFT) calculations using the M06/6-31G(d) method with the SDD basis
set for Au and a DCE solvent continuum (CPCM), as implemented in GAUSSIAN09.34–37
Two potential pathways for the rearrangement were examined, the first proceeding through
the originally envisioned Cope rearrangement/ring expansion, which initiates by Au(I)
activation of the alkylidene cyclopropane (A, Figure 2). Cyclization initiated by
complexation at this point of unsaturation is predicted to proceed with a barrier of 22 kcal/
mol (relative to B), passing through tertiary carbocation A1 to give the cyclooctenes A2/A3
in a stepwise formal [3s,3s] sigmatropic rearrangement that is exergonic by ~3–5 kcal/mol
(see the Supporting Information for additional details). From this point, a second
electrophilic cyclization is initated at the endocyclic alkene to give A4 (via A3-TS).38
Unexpectedly, no transition-state structure could be found to enable the direct ring
expansion of the cyclopropane in A4. Instead, a conformational change is needed (via A4-
TS) to orient the bonds and associated orbitals for facile ring expansion (see A5). Expansion
of the cyclopropane to the tetracyclic 6–5–4–3 intermediate C proceeds through A5-TS, the
highest energy transition-state structure in the predicted pathway. Deprotonation followed
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by protodemetalation provides the complexed product 2a, with the overall process being
exergonic by more than 25 kcal/mol.
An alternative pathway, which avoids formation of a cyclooctene intermediate but
converges with pathway A at structure A4, involves initiation of the Cope rearrangement at
the pendant alkene instead of the cyclopropylidene moiety. In this pathway, cyclization of B
to A4 proceeds directly through a transition-state structure (B-TS, 22.9 kcal/mol) that is only
slightly higher energy than A-TS.
The failure of substrates 1c–e was also probed computationally, and the results are
summarized in Table 1. First, each of these reactions was found to be at least slightly
endergonic, with each pathway suffering some additional deficiency. Substitution at R2
creates steric interactions with the cyclohexyl ring and increases the relative energy of A-
TS. In these cases ((Z)-1c and -1e), a transition-state structure leading from the starting
material to the ring-expanded product could not be located. In addition, compound (E)-1c,
rearranges through a secondary carbocation rather than a tertiary carbocation (cf. Figure 2).
While substrate 1d demonstrated an achievable ring-expansion barrier, the analogous A5-TS
was too high in energy (31 kcal/mol) for conversion to C. The source of this high barrier
appears to result from a steric clash between methyl groups.
In summary, we have described a Au(I)-catalyzed Cope rearrangement of cyclic
cyclopropylidenes into unique tricyclic compounds with a bicyclo[4.2.0]oct-1-ene core, a
structural motif present in several classes of natural products. The reaction proceeds
eficiently at room temperature to provide the products in good yields. Quantum chemical
calculations provide insight into the mechanism and thermodynamics of the reaction.
EXPERIMENTAL SECTION
All reagents were purchased from commercial sources and used as received unless otherwise
noted. All glassware was flame-dried under vacuum unless otherwise indicated. Anhydrous
CH2Cl2, diethyl ether, and pentanes were passed through a column of alumina. Column
chromatography was performed using SilaFlash P60 40–63 μm (230–400 mesh). All NMR
spectra were recorded on either a 600 or 400 MHz spectrometer at STP. 1H and 13C
chemical shifts are reported in parts per million (ppm) relative to residual solvent resonances
(CDCl3 or CD2Cl2). High-resolution mass spectra (EI/HRMS) were obtained on a double-
focusing magnetic sector spectrometer.
General Procedure A for Michael Addition Reactions (for Preparation of 3-Methyl-3-
(prop-1-en-2-yl)cyclohexanone)
To a flame-dried 100 mL round-bottom flask under N2 was added CuI (3.45 g, 18.2 mmol,
2.00 equiv) and then THF (18 mL). The reaction vessel was cooled to −41 °C before the
addition of the Grignard reagent, isopropenylmagnesium bromide (0.5 M THF, 36.3 mL,
18.2 mmol, 2.00 equiv), over 30 min. The reaction was stirred at −41 °C for 30 min before
the addition of 3-methyl-2-cyclohexen-1-one (1.03 mL, 9.08 mmol, 1.00 equiv) dissolved in
THF (9 mL) via cannula. The reaction was then stirred 1.5 h at −41 °C before being
quenched with saturated aqueous NH4Cl (50 mL). The aqueous layer was separated, and the
organic layer was washed two additional times with saturated aqueous NH4Cl. The
combined aqueous washes were then extracted with Et2O (2×). The combined organic layers
were washed with brine until the aqueous layer was no longer blue-tinted. The organic
layers were then dried over MgSO4, filtered, and concentrated in vacuo. Purification by
silica gel chromatography (15% EtOAc/petroleum ether) provided the product compound as
a yellow oil (1.30 g, 94% yield).
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General Procedure B for Wittig cyclopropylidination (for Preparation of 3-
Cyclopropylidene-1-methyl-1-(prop-1-en-2-yl)cyclohexane (1a))
To a Schlenk flask loaded with a suspension of dry NaH (0.102 g, 4.26 mmol, 1.30 equiv) in
THF (25 mL) under N2 atmosphere was added cyclopropyltriphenylphosphonium bromide
(1.63 g, 4.26 mmol, 1.30 equiv) at rt. The reaction flask was then equipped with a condenser
and heated to 62 °C for 18 h. To the resulting orange suspension were then added the ketone
(3-methyl-3-(prop-1-en-2-yl)cyclohexanone, 0.500 g, 3.28 mmol, 1.00 equiv) and tris[2-(2-
methoxyethoxy)ethyl]amine (TDA-1) (0.105 mL, 0.328 mmol, 0.10 equiv) in THF (6 mL).
The reaction was stirred for 5 h at 62 °C before being cooled to rt and quenched with
saturated aqueous NaHCO3. The reaction was diluted with deionized H2O and Et2O before
the layers were separated. The aqueous layer was extracted with Et2O (2×), and the
combined organic layers were then washed with brine (2×). The organic layer was then dried
over MgSO4, filtered, and concentrated in vacuo. Purification by silica gel chromatography
(hexanes) provided the product compound as a colorless oil (0.269 g, 47%). A small amount
of CH2Cl2 was used to load the material onto the column.
General Procedure C for Preparation and Use of (1-Phenylvinyl)magnesium Bromide
(Preparation of 3-Methyl-3-(1-phenylvinyl)cyclohexanone)
To a flame-dried 100-mL three-neck RBF equipped with a condenser under N2 atmosphere
were added Mg (0.467 g, 19.2 mmol, 2.12 equiv) and THF (32.3 mL) and a few small
crystals of I2. α-Bromostyrene (2.35 mL, 18.1 mmol, 2.00 equiv) was dissolved in THF (4
mL) and then added to the reaction mixture. The solution was heated to 70 °C for 5–15 min
until the consumption of Mg appeared to have stopped. After being cooled to room
temperature, the Grignard solution (~0.5 M) was transferred via cannula to a suspension of
CuI (3.45 g, 18.1 mmol, 1.00 equiv) in THF (36 mL) at −41 °C. The reaction was stirred at
−41 °C for 30 min before the addition of a solution of 3-methyl-2-cyclohexen-1-one (1.03
mL, 9.07 mmol, 1.00 equiv) dissolved in THF (9 mL) via cannula. The reaction was then
stirred 1.5 h at −41 °C before being quenched with saturated aqueous NH4Cl (50 mL). The
aqueous layer was separated, and the organic layer was washed two additional times with
saturated aqueous NH4Cl. The combined aqueous washes were then extracted with EtOAc
(2×). The combined organic layers were washed with brine until the aqueous layer was no
longer blue-tinted and finally dried over MgSO4, filtered, and concentrated in vacuo.
Purification by silica gel chromatography (15% EtOAc/petroleum ether) provided the
product compound as a yellow oil as a mixture with styrene (1.32 g total, 0.971 g product,
50% yield).
General Procedure D for Au(I)-Catalyzed Rearrangement (for Preparation of 6,7-
Dimethyltricyclo[5.3.1.0]undec-4-ene (2a))
To a 1-dram vial equipped with a stirbar was added Ph3PAuNTf2 (0.011 g, 0.0142 mmol,
0.10 equiv) followed by DCM (0.5 mL). The reaction was stirred briefly before addition of
1a (0.025g, 0.142 mmol, 1.00 equiv). The reaction was then stirred for 12 h before being
concentrated in vacuo. A pipet column was then used for purification by silica gel
chromatography (hexanes) to provide the product compound as a colorless oil (0.019 g,
76%). A small amount of DCM was used to add the material to the column.
3-Methyl-3-(prop-1-en-2-yl)cyclohexanone—Yellow oil (1.30 g, 94% yield) 1H NMR
(600 MHz, CDCl3): δ 4.80 (s, 1H), 4.71 (s, 1H), 2.58 (d, J = 14.4 Hz, 1H), 2.28 (dt, J = 15.0,
5.7 Hz, 1H), 2.22–2.18 (m, 1H), 2.17 (d, J = 14.4 Hz, 1H), 1.91–1.87 (m, 1H), 1.84–1.77 (m,
1H), 1.71–1.67 (m, 1H), 1.69 (s, 3H), 1.56 (ddd, J = 13.2, 9.6, 3.6 Hz, 1H), 1.06 (s, 3H); 13C
NMR (150 MHz, CDCl3): δ 211.9, 150.0, 112.0, 52.7, 43.9, 41.0, 35.0, 27.0, 22.0, 19.3.
HRMS (EI+): calcd for C10H16O 152.12012, found 152.12093.
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(0.269 g, 47% yield). 1H NMR (600 MHz, CDCl3): δ 4.74 (s, 1H), 4.73 (s, 1H), 2.41 (d, J =
13.2 Hz, 1H), 2.26–2.22 (m, 1H), 2.17–2.14 (m, 1H), 2.13 (d, J = 13.2 Hz, 1H), 1.71 (s, 3H),
1.71–1.68 (m, 1H), 1.55–1.50 (m, 2H), 1.47–1.44 (m, 1H), 0.99–0.96 (m, 4H), 0.94 (s,
3H); 13C NMR (150 MHz, CDCl3): δ 152.9, 126.1, 113.9, 109.4, 43.8, 41.0, 36.5, 33.2,
25.9, 23.4, 19.8, 2.13, 2.10. HRMS (EI+): calcd for C13H20 176.15650, found 176.15722.
3-Methyl-3-(1-phenylvinyl)cyclohexanone—Characterization data matched that
previously reported.39
(1-(3-Cyclopropylidene-1-methylcyclohexyl)vinyl)benzene (1b)—Synthesized
following general procedure B using 3-methyl-3-(1-phenyvinyl)cyclohexanone. Stirred 5 h
at 62 °C after addition of ketone in THF. Purified by silica gel chromatography (hexanes) to
give a colorless oil (0.281g, 36% yield). 1H NMR (400 MHz, CD2Cl2): δ 7.30–7.22 (m, 3H),
7.16–7.13 (m, 2H), 5.23 (d, J = 1.6 Hz, 1H), 4.82 (d, J = 1.6 Hz, 1H), 2.46 (d, J = 13.2 Hz,
1H), 2.31 (dt, J = 13.2, 5.2 Hz, 1H), 2.23 (d, J = 12.8 Hz, 1H), 2.15–2.09 (m, 1H), 1.75–1.69
(m, 1H), 1.68–1.60 (m, 1H), 1.59–1.46 (m, 2H), 1.06 (s, 3H), 1.02–0.89 (m, 4H); 13C NMR
(100 MHz, CD2Cl2): δ 159.6, 144.0, 129.7, 127.8, 126.8, 126.1, 114.5, 113.5, 44.5, 41.5,
37.2, 33.4, 25.9, 23.7, 2.21. HRMS (EI+): calcd for C18H22 238.17215, found 238.17139.
3-Methyl-3-(prop-1-enyl)cyclohexanone—Synthesized following general procedure A
using 1-propenylmagnesium bromide solution (0.5 M THF). Purified by silica gel
chromatography (15% EtOAc/petroleum ether) to give a yellow oil as a 1:1 inseperable
mixture of E/Z isomers (0.981 g, 71% yield). Spectroscopic data reported is of the mixture
of isomers. 1H NMR (600 MHz, CD2Cl2): δ 5.39 (ddt J = 12.0, 7.8, 7.2 Hz, 1H), 5.36–5.29
(m, 2H), 5.20 (dq, J = 11.7, 1.8 Hz, 1H), 2.45 (d, J = 13.2 Hz, 1H), 2.34 (dt, J = 13.8, 1.8 Hz,
1H), 2.22–2.16 (m, 5H), 2.10 (d, J = 13.8 Hz, 1H), 1.95–1.91 (m, 1H), 1.88–1.76 (m, 4H),
1.69 (dd, J = 7.2, 1.8 Hz, 3H), 1.64–1.55 (m, 3H), 1.62 (d, J = 4.8 Hz, 3H), 1.16 (s, 3H),
1.00 (s, 3H). 13C NMR (150 MHz, CD2Cl2): δ 211.6, 211.5, 139.4, 137.0, 125.6, 123.4,
55.1, 52.8, 41.7, 41.4, 41.3, 38.1, 37.5, 28.2, 27.6, 23.1, 22.7, 18.4, 14.8. HRMS (EI+): calcd
for C10H16O 152.12012, found 152.12048.
3-Cyclopropylidene-1-methyl-1-(prop-1-enyl)cyclohexane (1c)—Synthesized
following general procedure B using 3-methyl-3-(prop-1-enyl)cyclohexanone. Stirred 2.5 h
at 62 °C after addition of ketone in THF. Purified by silica gel chromatography (hexanes) to
give a colorless oil as a 1:1 inseparable mixture of E/Z isomers (0.185 g, 32% yield).
Spectroscopic data reported is of the mixture of isomers. 1H NMR (600 MHz, CD2Cl2): δ
5.43–5.36 (m, 1H), 5.35–5.29 (m, 2H), 5.23 (dq, J = 12.0, 1.8 Hz, 1H), 2.39 (d, J = 12.6 Hz,
1H), 2.29–2.23 (m, 1H), 2.21 (d, J = 13.2 Hz, 1H), 2.17–2.10 (m, 2H), 2.06 (d, J = 19.5 Hz,
1H), 2.04 (d, J = 19.8, 1H), 1.86–1.82 (m, 1H), 1.71 (dd, J = 7.2, 1.8 Hz, 3H), 1.63 (dd, J =
4.8, 1.2 Hz, 3H), 1.61–1.46 (m, 6H), 1.44–1.38 (m, 2H), 1.11 (s, 3H), 1.03–0.95 (m, 8H),
0.91 (s, 3H). 13C NMR (150 MHz, CD2Cl2): δ 141.9, 139.3, 126.4, 126.2, 123.9, 121.1,
114.2, 114.0, 47.7, 45.4, 39.3, 39.0, 38.9, 38.3, 33.5, 33.4, 27.2, 26.5, 24.2, 23.7, 18.6, 15.0,
2.21, 2.17, 2.11. HRMS (EI+): calcd for C13H20 176.15650, found 176.15742.
(E)-3-(But-2-en-2-yl)-3-methylcyclohexanone—Synthesized following general
procedure A using 1-methyl-1-propenylmagnesium bromide solution (0.5 M THF). Stirred
for 2 h at −41 °C after addition of enone. Purified by silica gel chromatography (15%
EtOAc/petroleum ether) to give a yellow oil; 3:1 ratio of inseparable diastereomers (1.13 g,
75% yield). Spectroscopic data reported is of the mixture of isomers. 1H NMR (600 MHz,
CD2Cl2): δ 5.31 (q, J = 7.8 Hz, 1H), 5.24 (q, J = 6.6 Hz, (1/3) = 1H, minor isomer), 2.69 (d,
J = 13.8 Hz, 1H), 2.54 (d, J = 14.4 Hz, (1/3) = 1H, minor isomer), 2.29–2.20 (m, 2H), 2.18–
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2.12 (m, 2H), 1.93–1.74 (m, 2H), 1.70–1.67 (m, 6H), 1.56–1.55 (m, 1H), 1.14 (s, 3H), 1.03
(s, (1) = 3H, minor isomer). 13C NMR (150 MHz, CD2Cl2): δ 211.9, 211.8, 140.9, 140.8,
121.7, 119.4, 54.1, 53.0, 44.7, 44.3, 41.4, 41.3, 36.3, 35.3, 27.2, 26.2, 24.2, 22.8, 22.4, 15.9,
14.0, 12.4. HRMS (EI+): calcd for C11H18O 166.13577, found 166.13636.
(E)-1-(But-2-en-2-yl)-3-cyclopropylidene-1-methylcyclohexane (1d)—Synthesized
following general procedure B using (E)-3-(but-2-en-2-yl)-3-methylcyclohexanone. Stirred
4.5 h at 62 °C after addition of ketone in THF. Purified by silica gel chromatography
(hexanes) to give a colorless oil as an inseparable 3:1 ratio of diastereomers (0.106 g, 17%
yield). Spectroscopic data reported is of the mixture of isomers. 1H NMR (600 MHz,
CD2Cl2): δ 5.33–5.30 (m, (1/3) = 1H, minor isomer), 5.26–5.23 (m, 1H), 2.54 (d, J = 13.2
Hz, 1H), 2.37 (d, J = 12.6 Hz, (1/3) = 1H, minor isomer), 2.28–2.24 (m, 1H), 2.20–2.16 (m,
1H), 2.13 (d, J = 13.2 Hz, 1H), 2.01–1.97 (m, 1H), 1.69 (bs, 6H), 1.60–1.50 (m, 3H), 1.06 (s,
3H), 0.99 (bs, 4H), 0.91 (s, (1) = 3H, minor isomer). 13C NMR (150 MHz, CD2Cl2): δ
143.23, 143.16, 126.9, 126.7, 120.3, 116.7, 114.1, 113.8, 45.4, 44.1, 41.64, 41.58, 37.6,
36.8, 33.6, 33.5, 25.5, 25.3, 24.03, 23.99, 23.7, 16.1, 14.0, 12.6, 2.4, 2.21, 2.19, 2.1. HRMS
(EI+): calcd for C14H22 190.17215, found 190.17239.
3-Methyl-3-(2-methylprop-1-enyl)cyclohexanone—Synthesized following general
procedure A using 2-methyl-1-propenylmagnesium bromide solution (0.5 M THF). Stirred
1.5 h at −41 °C after addition of enone. Purified by silica gel chromatography (15% EtOAc/
petroleum ether) to give a yellow oil (1.02 g, 68% yield). 1H NMR (600 MHz, CD2Cl2): δ
5.03 (s, 1H), 2.41 (d, J = 12.6 Hz, 1H), 2.21 (d, J = 4.8 Hz, 2H), 2.17 (d, J = 13.2 Hz, 1H),
1.93 (bs, 1H), 1.83 (bs, 2H), 1.71 (s, 3H), 1.67 (s, 3H), 1.60 (bs, 1H), 1.15 (s, 3H). 13C NMR
(150 MHz, CD2Cl2): δ 211.7, 133.6, 131.0, 55.6, 41.4, 40.9, 38.3, 28.3, 27.6, 23.1, 19.5.
HRMS (EI+): calcd for C11H18O 166.13577, found 166.13609.
3-Cyclopropylidene-1-methyl-1-(2-methylprop-1-enyl)-cyclohexane (1e)—
Synthesized following general procedure B using 3-methyl-3-(2-methylprop-1-
enyl)cyclohexanone. Stirred 3 h at 62 °C after addition of ketone in THF. Purified by silica
gel chromatography (hexanes) to give a colorless oil (0.206 g, 33% yield). 1H NMR (600
MHz, CD2Cl2): δ 5.04 (s, 1H), 2.35 (d, J = 13.2 Hz, 1H), 2.26–2.24 (m, 1H), 2.12 (bs, 1H),
2.02 (d, J = 12.6 Hz, 1H) 1.82–1.79 (m, 1H), 1.70 (s, 3H), 1.64 (s, 3H) 1.57–1.54 (m, 1H),
1.51–1.45 (m, 1H), 1.42–1.38 (m, 1H), 1.08 (s, 3H), 1.03–0.98 (m, 4H); 13C NMR (150
MHz, CD2Cl2): δ 133.5, 131.4, 126.6, 114.1, 48.0, 39.5, 38.0, 33.5, 28.3, 27.1, 24.2, 19.5,
2.2, 2.1. HRMS (EI+): calcd for C14H22 190.17215, found 190.17146.
3-Methyl-3-(prop-1-en-2-yl)cyclopentanone—Synthesized following general
procedure A using isopropenylmagnesium bromide (0.5 M THF) and 3-methylcyclopent-2-
enone. Stirred 1.5 h at −41 °C after addition of enone. This material was sufficiently pure to
be taken on without further purification as a yellow oil (0.991 g, 79% yield). 1H NMR (600
MHz, CD2Cl2): δ 4.78 (t, J = 1.8 Hz, 1H), 4.71 (s, 1H), 2.38 (d, J = 17.4 Hz, 1H), 2.28–2.24
(m, 2H), 2.09 (d, J = 17.4 Hz, 1H), 2.07–2.02 (m, 1H), 1.88–1.84 (m, 1H), 1.79 (s, 3H), 1.17
(s, 3H). 13C NMR (150 MHz, CD2Cl2): δ 218.9, 151.6, 109.5, 51.6, 45.3, 37.1, 34.3, 25.9,
19.8. HRMS (EI+): calcd for C9H14O 138.10447, found 138.10502.
3-Cyclopropylidene-1-methyl-1-(prop-1-en-2-yl)cyclopentane (3a)—Synthesized
following general procedure B using 3-methyl-3-(prop-1-en-2-yl)cyclopentanone. Stirred 5
h at 62 °C after addition of ketone in THF. Purified by silica gel chromatography (hexanes)
to give a colorless oil (0.096g, 18% yield). 1H NMR (600 MHz, CDCl3): δ 4.70 (s, 1H), 4.68
(s, 1H), 2.47–2.41 (m, 3H), 2.23 (d, J = 15.0 Hz, 1H), 1.82–1.77 (m, 1H), 1.76 (s, 3H), 1.63–
1.58 (m, 1H), 1.04 (s, 3H), 0.97–0.95 (m, 4H). 13C NMR (150 MHz, CDCl3): δ 153.1,
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130.6, 111.4, 108.2, 47.7, 44.7, 37.2, 30.0, 25.4, 20.3, 2.5, 2.4. HRMS (EI+): calcd for
C12H19 (M + 1) 163.14868, found 163.14901.
3-Methyl-3-(1-phenylvinyl)cyclopentanone—Synthesized following general
procedure C using 3-methylcyclopent-2-enone. Stirred 4 h at −41 °C after addition of enone.
Puri3cation by gradient silica gel chromatography (petroleum ether to 95:5 petroleum ether/
Et2O to 90:5:5 petroleum ether/Et2O/EtOAc) provided the product compound as a yellow oil
(0.327g, 18% yield). 1H NMR (600 MHz, CDCl3): δ 7.31–7.26 (m, 3H), 7.15–7.14 (m, 2H),
5.17 (s, 1H), 4.96 (s, 1H), 2.50 (d, J = 17.4 Hz, 1H), 2.31–2.28 (m, 2H), 2.20–2.14 (m, 1H),
2.15 (dd, J = 17.4, 1.8 Hz, 1H), 1.86 (ddt, J = 9.6, 6.6, 1.8 Hz, 1H), 1.25 (s, 3H). 13C NMR
(150 MHz, CDCl3): δ 218.8, 156.4, 142.3, 128.8, 128.0, 127.2, 113.8, 51.9, 45.2, 36.7, 34.5,
26.6. HRMS (EI+): calcd for C14H16O 200.12012, found 200.11936.
(1-(3-Cyclopropylidene-1-methylcyclopentyl)vinyl)benzene (3b)—Synthesized
following general procedure B using 3-methyl-3-(1-phenylvinyl)cyclopentanone. Stirred 8.5
h at 62 °C after addition of ketone in THF. Purified by silica gel chromatography (hexanes)
to give a colorless oil (0.221 g, 30% yield). 1H NMR (600 MHz, CDCl3): δ 7.29–7.24 (m,
3H), 7.20–7.18 (m, 2H), 5.17 (d, J = 1.2 Hz, 1H), 4.87 (d, J = 1.2 Hz, 1H), 2.57 (d, J = 15.6
Hz, 1H), 2.44 (bs, 2H), 2.26 (d, J = 15.6 Hz, 1H), 1.97–1.92 (m, 1H), 1.66–1.62 (m, 1H),
1.13 (s, 3H), 0.96–0.94 (m, 4H). 13C NMR (150 MHz, CDCl3): δ 158.4, 143.7, 130.3, 128.8,
127.7, 126.7, 112.6, 111.7, 47.8, 45.4, 37.8, 29.8, 26.2, 2.5, 2.4. HRMS (EI+): calcd for
C17H20 224.15650, found 224.15584.
3-(1-Phenylvinyl)cycloheptanone—Synthesized following general procedure C using
2-cyclohepten-1-one. Stirred 1.5 h at −41 °C after addition of enone. Purification by gradient
silica gel chromatography (petroleum ether to 95:5 petroleum ether/Et2O to 90:5:5
petroleum ether/Et2O/EtOAc) provided the product compound as a pale yellow oil (1.13 g,
58% yield). 1H NMR (400 MHz, CDCl3): δ 7.32–7.31 (m, 4H), 7.29–7.26 (m, 1H), 5.19 (s,
1H), 5.02 (s, 1H), 2.82 (t, J = 10.4 Hz, 1H), 2.70–2.61 (m, 1H), 2.69 (t, J = 14.4 Hz, 1H),
2.55–2.51 (m, 2H), 2.07–2.03 (m, 1H), 1.99–1.90 (m, 2H), 1.69–1.59 (m, 1H), 1.52–1.35
(m, 2H). 13C NMR (100 MHz, CDCl3): δ 214.1, 154.0, 142.0, 128.6, 127.7, 126.8, 111.7,
49.7, 44.2, 41.0, 37.3, 29.3, 24.4. HRMS (EI+): calcd for C15H18O 214.13577, found
214.13519.
1-Cyclopropylidene-3-(1-phenylvinyl)cycloheptane (4a)—Synthesized following
general procedure B using 3-(1-phenylvinyl)-cycloheptanone. Stirred 3.5 h at 62 °C after
addition of ketone in THF. Purified by silica gel chromatography (hexanes) to give a
colorless oil (0.367 g, 47% yield). 1H NMR (400 MHz, CDCl3): δ 7.39–7.37 (m, 2H), 7.33–
7.29 (m, 2H), 7.27-7.25 (m, 1H), 5.19 (s, 1H), 5.06 (s, 1H), 2.71 (d, J = 14.0 Hz, 1H), 2.64
(t, J = 10.4 Hz, 1H), 2.52 (d, J = 14.8 Hz, 1H), 2.42–2.36 (m, 1H), 2.28 (t, J = 12.4 Hz, 1H),
1.94–1.91 (m, 1H), 1.85–1.79 (m, 2H), 1.56–1.49 (m, 1H), 1.44–1.30 (m, 2H), 0.99–0.93
(m, 4H). 13C NMR (100 MHz, CDCl3): δ 155.7, 143.0, 128.9, 128.4, 127.3, 126.8, 116.8,
110.6, 44.9, 41.0, 36.7, 34.6, 28.5, 27.8, 2.35. HRMS (EI+): calcd for C18H22 238.17215,
found 238.17115.
6,7-Dimethyltricyclo[5.3.1.0]undec-4-ene (2a)—Colorless oil (0.019 g, 76%). 1H
NMR (600 MHz, CDCl3): δ.5.17 (s, 1H), 2.82–2.75 (m, 1H), 2.50–2.46 (m, 1H), 2.01 (bs,
1H), 1.74–1.70 (m, 3H), 1.63 (dd, J = 13.8, 2.4 Hz, 1H), 1.50–1.40 (m, 3H), 1.32 (dt, J =
12.3, 4.2 Hz, 1H), 1.26 (d, J = 11.4 Hz, 1H), 0.94 (d, J = 7.2 Hz, 3H), 0.87 (dt, J = 13.8, 5.4
Hz, 1H), 0.84 (s, 3H). 13C NMR (150 MHz, CDCl3): δ 143.1, 121.7, 48.9, 46.5, 42.2, 35.8,
34.9, 33.4, 32.5, 30.8, 28.9, 22.2, 14.7. HRMS (EI+): calcd for C13H20 176.15650, found
176.15578.
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7-Methyl-6-phenyltricyclo[5.3.1.0]undec-4-ene (2b)—Synthesized following general
procedure D using compound 1b. Purified by silica gel chromatography (hexanes) to give a
colorless oil (0.022 g, 88% yield). 1H NMR (600 MHz, CDCl3): δ 7.31–7.26 (m, 4H), 7.22–
7.20 (m, 1H), 5.37 (s, 1H), 3.35 (s, 1H), 2.95–2.88 (m, 1H), 2.59 (dt, J = 13.8, 5.4 Hz, 1H),
1.91–1.88 (m, 1H), 1.84–1.76 (m, 3H), 1.70 (d, J = 10.8 Hz, 1H), 1.45–1.41 (m, 3H), 1.07–
1.04 (m, 1H), 0.97 (s, 3H), 0.79 (dt, J = 13.8 5.4 Hz, 1H). 13C NMR (150 MHz, CDCl3): δ
145.2, 142.7, 130.0, 127.8, 126.2, 119.4, 55.4, 49.7, 46.4, 36.3, 35.4, 33.7, 32.6, 31.4, 29.3,
22.5. HRMS (EI+): calcd for C18H22 238.17215, found 238.17229.
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Selected NOESY correlations in NMR spectrum of bicyclo[4.2.0]oct-1-ene 2b. 3D
representations made in PyMOL.28–32
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Computed relative free energies (kcal/mol) for species involved in potential rearrangements
of 1a.
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Synthesis of Cyclic Substrates
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